Phase 4 Antiplatelet Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome
Coronary Artery DiseaseAntiplatelet Drugs
Shanghai Zhongshan Hospital2,846 enrolled1 locationNCT06451198
Recruiting
Phase 4
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
Dual Antiplatelet TherapyST Elevated Myocardial Infarction
Research Maatschap Cardiologen Rotterdam Zuid1,656 enrolled26 locationsNCT05491200
Recruiting
Phase 4
Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Ischemic STROKE（PATH-STROKE）
Ischemic StrokeAntiplatelet Drug
Sichuan Provincial People's Hospital1,020 enrolled1 locationNCT06269432
Recruiting
Phase 4
Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)
Antiplatelet TherapyHemorrhagic Infarction
Second Affiliated Hospital, School of Medicine, Zhejiang University294 enrolled1 locationNCT04624295
Recruiting
Phase 4
Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation
Perioperative CareAntiplatelet Agents
Kyoto University1,200 enrolled1 locationNCT06723145
Recruiting
Phase 4
Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial
AspirinAortic StenosisTAVI(Transcatheter Aortic Valve Implantation)+2 more
OCEAN-SHD Study Group400 enrolled1 locationNCT06007222